Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

KROSKROS
17 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in KEROS THERAPEUTICS INC

Qube Research & Technologies Ltd holds 608,837 shares of KROS (KEROS THERAPEUTICS INC), worth $6.5M as of 2026-Q2. The position was decreased (-16.0% shares). KROS represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$6.5M

Current Shares

608,837

Total Value Change

+$5M

Total Shares Change

+554,806

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
608,837
-16.0%
$6.5M0.0%$10.70
0
2026-Q1
Decreased
724,926
-7.5%
$8M0.0%$13.40
0
2025-Q4
Increased
783,918
+158.6%
$16M0.0%$20.27
45
2025-Q3
Increased
303,122
+683.7%
$4.8M0.0%$15.95
43
2025-Q2
Decreased
38,677
-85.8%
$516,3380.0%$13.49
0
2025-Q1
New
273,342
-
$2.8M0.0%$10.79
36
2024-Q4
Exited
0
-100.0%
$00.0%$15.64
0
2024-Q3
Decreased
27,941
-10.6%
$1.6M0.0%$56.45
0
2024-Q2
Increased
31,235
+1280.9%
$1.4M0.0%$45.70
41
2024-Q1
Decreased
2,262
-93.5%
$149,7440.0%$66.20
0
2023-Q4
Increased
34,542
+285.6%
$1.4M0.0%$39.76
41
2023-Q3
Decreased
8,958
-66.6%
$285,5810.0%$31.88
0
2023-Q2
Decreased
26,838
-28.6%
$1.1M0.0%$39.87
0
2023-Q1
Increased
37,611
+189.8%
$1.6M0.0%$42.13
41
2022-Q4
Decreased
12,980
-41.0%
$623,3000.0%$48.02
0
2022-Q3
Decreased
22,016
-59.3%
$828,0000.0%$36.31
0
2022-Q2
New
54,031
-
$1.5M0.0%$27.18
35

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used